ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1022

Declining In-hospital Mortality Gap in Lupus Compared to Non-lupus Hospitalizations: A National Study

Jasvinder Singh1 and John Cleveland1, 1University of Alabama at Birmingham, Birmingham, AL

Meeting: ACR Convergence 2020

Keywords: Administrative Data, Epidemiology, Health Services Research, Mortality, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Epidemiology & Public Health Poster III: Inflammatory Rheumatic Disease

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Lupus is a serious, multi-system autoimmune disease that affects young people. Mortality is increased by over 2-3 fold compared to the general population. Time-trends showed a reduction in mortality in a multicentric lupus cohort from 1970 to 2001 and in a U.S. population-based lupus cohort from 1950 to 1992. In contrast, in a study using the U.S. National center for Health Statistics and National Inpatient Sample (NIS) data, in-hospital mortality was 2.9% and it increased from 1978 to 1998. Given these contradictory time-trends and the lack of contemporary data in lupus, an updated study of mortality are needed. Our objective was to assess the time-trends in in-hospital mortality rates in people with lupus hospitalized in the U.S. from 1998 to 2014, and compare it to people without lupus.

Methods: We included discharges from the Healthcare Cost and Utilization Project (HCUP) National Inpatient Sample (NIS) for 1998 through 2014, the last year of the use of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). The NIS is a 20% stratified sample of hospital discharges which is designed for creating national estimates.
We identified primary lupus hospitalizations based on the presence of an ICD-9-CM code of 710.0x in the primary position; this diagnostic code approach has a sensitivity of 98% and specificity of 72%.

We calculated the unadjusted in-hospital mortality rates per 1,000 hospitalizations for people with versus without primary lupus hospitalizations, with the respective denominators. Rates were adjusted by age, grouped in quintiles (< 20, 20-39, 40-59, 60-79, >79) then by age and sex. We analyzed for time-trends in rates over time using Cochran Armitage test, weighted by the number of hospitalizations in each year.

Results: The 241,130 primary lupus hospitalizations in 1998-2014 included predominantly black (34.3%), young (45% were 20-39 years; mean age, 36 years) and female (86.9%) patients. Deyo-Charlson comorbidity score was ≥2 for 47%, approximately 1/3rd were receiving Medicaid and 1.5% died during the index hospitalization (Table 1).

Unadjusted mortality in primary lupus hospitalizations decreased by 45.2% from 17.9 in 1998 to 9.5 per 1,000 in 2014, versus a 25.9% reduction in non-lupus (28.1 to 21.2 per 1,000; Figure 1). Age and sex-adjusted mortality gap by lupus also decreased: primary lupus hospitalization, 17.6 per 1,000 claims in 1998 to 13.8 in 2014 (21.5% reduction), versus 15.1 per 1,000 claims in 1998 to 13.2 in 2014 in non-lupus (12.5% reduction; Figure 1; Table 2). This caused the line of mortality rates for those with primary lupus hospitalization to overlap with that of the rest of the population. The number of primary lupus hospitalizations remained fairly constant at 12-15,000 per year 1998-2014 (i.e., 0.04% of all NIS claims), and the rate per 100,000 NIS claims was 40.3 in 1998-2000 versus 34.9 in 2013-2014; the annual rates of total NIS hospitalizations were also stable 1998-2014.

The lupus to non-lupus mortality rate ratio was 1.17 in 1998 and 1.04 in 2014. 

Conclusion: The reduction in in-hospital mortality in people with lupus exceeded than in non-lupus, including age-and sex-adjusted. The improved in-hospital mortality in lupus is encouraging.

Figure 1. Time-trends in unadjusted (A) and age- and sex-adjusted (B) in-hospital mortality rates per 1,000 population of hospitalizations in people with lupus compared to people without lupus A. Unadjusted B. Age- and sex- adjusted Figure legend X-axis shows the calendar year. Y-axis shows the mortality rate per 1,000 hospitalizations with the respective denominators of primary lupus diagnosis hospitalizations for lupus and all other hospitalizations for non- lupus

Table 1. Characteristics of hospitalizations in people with lupus

Table 2. Comparison of Mortality rates per 1,000 hospitalized people between lupus vs. non-lupus: unadjusted based on the NIS sample; age- and age- and sex-adjusted rates based on the NIS sample and the census data


Disclosure: J. Singh, Crealta/Horizon, 1, Medisys, 1, Fidia, 1, UBM LLC, 1, Trio health, 1, Medscape, 1, WebMD, 1, Clinical Care options, 1, Clearview healthcare partners, 1, Putnam associates, 1, Focus forward, 1, Navigant consulting, 1, Spherix, 1, Practice Point communications, 1, the National Institutes of Health, 1, the American College of Rheumatology, 1, Amarin pharmaceuticals, 1, Viking therapeutics, 1, OMERACT, 1; J. Cleveland, None.

To cite this abstract in AMA style:

Singh J, Cleveland J. Declining In-hospital Mortality Gap in Lupus Compared to Non-lupus Hospitalizations: A National Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/declining-in-hospital-mortality-gap-in-lupus-compared-to-non-lupus-hospitalizations-a-national-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/declining-in-hospital-mortality-gap-in-lupus-compared-to-non-lupus-hospitalizations-a-national-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology